AXQ Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$119K Buy
+13,317
New +$119K 0.04% 505
2023
Q4
Sell
-23,134
Closed -$164K 645
2023
Q3
$164K Buy
23,134
+5,600
+32% +$39.6K 0.06% 403
2023
Q2
$123K Sell
17,534
-1,300
-7% -$9.15K 0.15% 229
2023
Q1
$157K Buy
+18,834
New +$157K 0.06% 425